Proteasome inhibitors enhance bacteriophage lambda (λ) mediated gene transfer in mammalian cells

Virology

Volumn 384, Issue 1, 2009, Pages 77-87

  Volcy, Ketna ^a   Dewhurst, Stephen ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Bacteriophage lambda; Cathepsin; Endocytosis; Gene transfer; Lysosomal protease; Proteasome; Virus vector

Indexed keywords

BAFILOMYCIN A1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; CHLOROQUINE; LACTACYSTIN; LUCIFERASE; OMEPRAZOLE; PROTEASOME INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; VIRUS VECTOR;

ACIDIFICATION; ANIMAL CELL; ARTICLE; BACTERIOPHAGE LAMBDA; CELL STRAIN COS7; CELL STRAIN HEK293; CONCENTRATION (PARAMETERS); DEFENSE MECHANISM; ENDOSOME; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; GENE CASSETTE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; GENOME; INFECTION; INNATE IMMUNITY; LYSOSOME; MAMMAL CELL; MICROBIAL DEGRADATION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEINASE INHIBITION; REPORTER GENE; VIRUS;

AMINO ACID SEQUENCE; ANIMALS; BACTERIOPHAGE LAMBDA; CAPSID PROTEINS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOSOMES; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSDUCTION, GENETIC;

ENTEROBACTERIA PHAGE LAMBDA; MAMMALIA;

EID: 58549103288     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.11.019     Document Type: Article

References (71)

1. Akache B., Grimm D., Shen X., Fuess S., Yant S.R., Glazer D.S., Park J., and Kay M.A. A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8. Mol. Ther. 15 2 (2007) 330-339
2. Baer G.S., Ebert D.H., Chung C.J., Erickson A.H., and Dermody T.S. Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly. J. Virol. 73 11 (1999) 9532-9543
3. Baker M.L., Jiang W., Rixon F.J., and Chiu W. Common ancestry of herpesviruses and tailed DNA bacteriophages. J. Virol. 79 23 (2005) 14967-14970
4. Bamford D.H., Burnett R.M., and Stuart D.I. Evolution of viral structure. Theor. Popul. Biol. 61 4 (2002) 461-470
5. Bearden C.M., Agarwal A., Book B.K., Vieira C.A., Sidner R.A., Ochs H.D., Young M., and Pescovitz M.D. Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174. Am. J. Transp. 5 1 (2005) 50-57
6. Benson S.D., Bamford J.K., Bamford D.H., and Burnett R.M. Does common architecture reveal a viral lineage spanning all three domains of life?. Mol. Cell 16 5 (2004) 673-685
7. Blumenthal R., Bali-Puri A., Walter A., Covell D., and Eidelman O. pH-dependent fusion of vesicular stomatitis virus with Vero cells. Measurement by dequenching of octadecyl rhodamine fluorescence. J. Biol. Chem. 262 28 (1987) 13614-13619
8. Booth J.W., Kim M.K., Jankowski A., Schreiber A.D., and Grinstein S. Contrasting requirements for ubiquitylation during Fc receptor-mediated endocytosis and phagocytosis. EMBO J. 21 3 (2002) 251-258
9. Bruttin A., and Brussow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob. Agents Chemother. 49 7 (2005) 2874-2878
10. Chandran K., Sullivan N.J., Felbor U., Whelan S.P., and Cunningham J.M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308 5728 (2005) 1643-1645
11. Chauhan D., Hideshima T., Mitsiades C., Richardson P., and Anderson K.C. Proteasome inhibitor therapy in multiple myeloma. Mol. Cancer Ther. 4 4 (2005) 686-692
12. Chen Y.T., Lin C.H., Ji W.T., Li S.K., and Liu H.J. Proteasome inhibition reduces avian reovirus replication and apoptosis induction in cultured cells. J. Virol. Methods 151 1 (2008) 95-100
13. Clark J.R., and March J.B. Bacteriophage-mediated nucleic acid immunisation. FEMS Immunol. Med. Microbiol. 40 1 (2004) 21-26
14. Coulibaly F., Chevalier C., Gutsche I., Pous J., Navaza J., Bressanelli S., Delmas B., and Rey F.A. The birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell 120 6 (2005) 761-772
15. Davison A.J. Evolution of the herpesviruses. Vet. Microbiol. 86 1-2 (2002) 69-88
16. Ding W., Zhang L.N., Yeaman C., and Engelhardt J.F. rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion. Mol. Ther. 13 4 (2006) 671-682
17. Douar A.M., Poulard K., Stockholm D., and Danos O. Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J. Virol. 75 4 (2001) 1824-1833
18. Dunn I.S. Mammalian cell binding and transfection mediated by surface-modified bacteriophage lambda. Biochimie 78 10 (1996) 856-861
19. Ebert D.H., Deussing J., Peters C., and Dermody T.S. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J. Biol. Chem. 277 27 (2002) 24609-24617
20. Eguchi A., Akuta T., Okuyama H., Senda T., Yokoi H., Inokuchi H., Fujita S., Hayakawa T., Takeda K., Hasegawa M., and Nakanishi M. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 276 28 (2001) 26204-26210
21. Eguchi A., Furusawa H., Yamamoto A., Akuta T., Hasegawa M., Okahata Y., and Nakanishi M. Optimization of nuclear localization signal for nuclear transport of DNA-encapsulating particles. J. Control. Release 104 3 (2005) 507-519
22. Funk A., Mhamdi M., Hohenberg H., Will H., and Sirma H. pH-independent entry and sequential endosomal sorting are major determinants of hepadnaviral infection in primary hepatocytes. Hepatology 44 3 (2006) 685-693
23. Geier M.R., and Merril C.R. Lambda phage transcription in human fibroblasts. Virology 47 3 (1972) 638-643
24. Golden J.W., Bahe J.A., Lucas W.T., Nibert M.L., and Schiff L.A. Cathepsin S supports acid-independent infection by some reoviruses. J. Biol. Chem. 279 10 (2004) 8547-8557
25. Heldwein E.E., Lou H., Bender F.C., Cohen G.H., Eisenberg R.J., and Harrison S.C. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313 5784 (2006) 217-220
26. Ito Y., Kawamura I., Kohda C., Baba H., Nomura T., Kimoto T., Watanabe I., and Mitsuyama M. Seeligeriolysin O, a cholesterol-dependent cytolysin of Listeria seeligeri, induces gamma interferon from spleen cells of mice. Infect. Immun. 71 1 (2003) 234-241
27. Ito Y., Kawamura I., Kohda C., Tsuchiya K., Nomura T., and Mitsuyama M. Seeligeriolysin O, a protein toxin of Listeria seeligeri, stimulates macrophage cytokine production via Toll-like receptors in a profile different from that induced by other bacterial ligands. Int. Immunol. 17 12 (2005) 1597-1606
28. Jane-Valbuena J., Breun L.A., Schiff L.A., and Nibert M.L. Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein sigma3. J. Virol. 76 10 (2002) 5184-5197
29. Jennings K., Miyamae T., Traister R., Marinov A., Katakura S., Sowders D., Trapnell B., Wilson J.M., Gao G., and Hirsch R. Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo. Mol. Ther. 11 4 (2005) 600-607
30. Jepson C.D., and March J.B. Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Vaccine 22 19 (2004) 2413-2419
31. Khor R., McElroy L.J., and Whittaker G.R. The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic 4 12 (2003) 857-868
32. Kisselev A.F., and Goldberg A.L. Proteasome inhibitors: from research tools to drug candidates. Chem. Biol. 8 8 (2001) 739-758
33. Lakadamyali M., Rust M.J., and Zhuang X. Endocytosis of influenza viruses. Microbes Infect. 6 10 (2004) 929-936
34. LaLonde J.M., Zhao B., Smith W.W., Janson C.A., DesJarlais R.L., Tomaszek T.A., Carr T.J., Thompson S.K., Oh H.J., Yamashita D.S., Veber D.F., and Abdel-Meguid S.S. Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites. J. Med. Chem. 41 23 (1998) 4567-4576
35. Lankes H.A., Zanghi C.N., Santos K., Capella C., Duke C.M., and Dewhurst S. In vivo gene delivery and expression by bacteriophage lambda vectors. J. Appl. Microbiol. 102 5 (2007) 1337-1349
36. March J.B., Clark J.R., and Jepson C.D. Genetic immunisation against hepatitis B using whole bacteriophage lambda particles. Vaccine 22 13-14 (2004) 1666-1671
37. Mego J.L. Role of thiols, pH and cathepsin D in the lysosomal catabolism of serum albumin. Biochem J. 218 3 (1984) 775-783
38. Merril C.R., Geier M.R., and Petricciani J.C. Bacterial virus gene expression in human cells. Nature 233 5319 (1971) 398-400
39. Moriuchi H., Moriuchi M., and Fauci A.S. Cathepsin G, a neutrophil-derived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infection. J. Virol. 74 15 (2000) 6849-6855
40. Newcomb W.W., Juhas R.M., Thomsen D.R., Homa F.L., Burch A.D., Weller S.K., and Brown J.C. The UL6 gene product forms the portal for entry of DNA into the herpes simplex virus capsid. J. Virol. 75 22 (2001) 10923-10932
41. Ochs H.D., Davis S.D., and Wedgwood R.J. Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. J. Clin. Invest. 50 12 (1971) 2559-2568
42. Pager C.T., and Dutch R.E. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J. Virol. 79 20 (2005) 12714-12720
43. Parker J.S., and Parrish C.R. Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking. J. Virol. 74 4 (2000) 1919-1930
44. Qiu Z., Hingley S.T., Simmons G., Yu C., Das Sarma J., Bates P., and Weiss S.R. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J. Virol. 80 12 (2006) 5768-5776
45. Rechsteiner M., and Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21 7 (1996) 267-271
46. Roche S., Bressanelli S., Rey F.A., and Gaudin Y. Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science 313 5784 (2006) 187-191
47. Ros C., and Kempf C. The ubiquitin-proteasome machinery is essential for nuclear translocation of incoming minute virus of mice. Virology 324 2 (2004) 350-360
48. Ros C., Burckhardt C.J., and Kempf C. Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction. J. Virol. 76 24 (2002) 12634-12645
49. Sanchez A. Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J. Infect. Dis. 196 Suppl. 2 (2007) S251-258
50. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25 51 (2006) 6685-6705
51. Schornberg K., Matsuyama S., Kabsch K., Delos S., Bouton A., and White J. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80 8 (2006) 4174-4178
52. Schwartz O., Marechal V., Friguet B., Arenzana-Seisdedos F., and Heard J.M. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72 5 (1998) 3845-3850
53. Simmons G., Gosalia D.N., Rennekamp A.J., Reeves J.D., Diamond S.L., and Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. U. S. A. 102 33 (2005) 11876-11881
54. Steven A.C., Heymann J.B., Cheng N., Trus B.L., and Conway J.F. Virus maturation: dynamics and mechanism of a stabilizing structural transition that leads to infectivity. Curr. Opin. Struct. Biol. 15 2 (2005) 227-236
55. Summers W.C. Bacteriophage therapy. Annu. Rev. Microbiol. 55 (2001) 437-451
56. Superti F., Seganti L., Ruggeri F.M., Tinari A., Donelli G., and Orsi N. Entry pathway of vesicular stomatitis virus into different host cells. J. Gen. Virol. 68 Pt 2 (1987) 387-399
57. Tanaka K., and Chiba T. The proteasome: a protein-destroying machine. Genes Cells 3 8 (1998) 499-510
58. Tang S.C., Sambanis A., and Sibley E. Proteasome modulating agents induce rAAV2-mediated transgene expression in human intestinal epithelial cells. Biochem. Biophys. Res. Commun. 331 4 (2005) 1392-1400
59. Uddin S., Ahmed M., Bavi P., El-Sayed R., Al-Sanea N., AbdulJabbar A., Ashari L.H., Alhomoud S., Al-Dayel F., Hussain A.R., and Al-Kuraya K.S. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer. Cancer Res. 68 9 (2008) 3379-3388
60. van Kerkhof P., and Strous G.J. The ubiquitin-proteasome pathway regulates lysosomal degradation of the growth hormone receptor and its ligand. Biochem. Soc. Trans. 29 Pt 4 (2001) 488-493
61. van Weert A.W., Dunn K.W., Gueze H.J., Maxfield F.R., and Stoorvogel W. Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump. J. Cell Biol. 130 4 (1995) 821-834
62. Wibo M., and Poole B. Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1. J Cell Biol 63 2 Pt 1 (1974) 430-440
63. Wiethoff C.M., Wodrich H., Gerace L., and Nemerow G.R. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J. Virol. 79 4 (2005) 1992-2000
64. Wojcik C., and DeMartino G.N. Intracellular localization of proteasomes. Int. J. Biochem. Cell Biol. 35 5 (2003) 579-589
65. Wu X., Anderson J.L., Campbell E.M., Joseph A.M., and Hope T.J. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc. Natl. Acad. Sci. U. S. A. 103 19 (2006) 7465-7470
66. Wullaert A., Heyninck K., Janssens S., and Beyaert R. Ubiquitin: tool and target for intracellular NF-kappaB inhibitors. Trends Immunol. 27 11 (2006) 533-540
67. Yan Z., Zak R., Luxton G.W., Ritchie T.C., Bantel-Schaal U., and Engelhardt J.F. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J. Virol. 76 5 (2002) 2043-2053
68. Yan Z., Zak R., Zhang Y., Ding W., Godwin S., Munson K., Peluso R., and Engelhardt J.F. Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia. J. Virol. 78 6 (2004) 2863-2874
69. Zanghi C.N., Lankes H.A., Bradel-Tretheway B., Wegman J., and Dewhurst S. A simple method for displaying recalcitrant proteins on the surface of bacteriophage lambda. Nucleic Acids Res. 33 18 (2005) e160
70. Zanghi C.N., Sapinoro R., Bradel-Tretheway B., and Dewhurst S. A tractable method for simultaneous modifications to the head and tail of bacteriophage lambda and its application to enhancing phage-mediated gene delivery. Nucleic Acids Res. 35 8 (2007) e59
71. Zhong L., Li B., Mah C.S., Govindasamy L., Agbandje-McKenna M., Cooper M., Herzog R.W., Zolotukhin I., Warrington Jr. K.H., Weigel-Van Aken K.A., Hobbs J.A., Zolotukhin S., Muzyczka N., and Srivastava A. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc. Natl. Acad. Sci. U. S. A. 105 22 (2008) 7827-7832